跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 73 条关于
“CAN016”
全部
73
临床试验
43
药物
23
机构
0
资讯
7
5个月前
CanWell Pharma Receives FDA Clearance for CAN016 Dual-Payload ADC in HER2-Positive Tumors
去年
Cantargia Expands CAN10 Development to Target Treatment-Resistant Atopic Dermatitis
去年
Cantargia's CAN10 Shows Promising Phase 1 Results for Hidradenitis Suppurativa Treatment
去年
Cantargia Expands Phase I Trial of CAN10 Antibody for Inflammatory Diseases
去年
Cantargia's CAN10 Demonstrates Promising Biomarker Results and Safety in Phase 1 Trial
去年
Cantargia Advances Nadunolimab Development Following TRIFOUR Trial Results, Secures Otsuka Partnership for CAN10 Program
去年
Otsuka Pharmaceutical Acquires Cantargia's CAN10 Antibody Program for $33 Million Upfront in Autoimmune Disease Deal